DE60013526D1 - Zusammensetzung enthaltend Verbindungen mit adrenergischer Aktivität und pflanzliche Extrakten von Crataegus und Gingko zur Behandlung von Übergewicht und Fettleibigkeit - Google Patents

Zusammensetzung enthaltend Verbindungen mit adrenergischer Aktivität und pflanzliche Extrakten von Crataegus und Gingko zur Behandlung von Übergewicht und Fettleibigkeit

Info

Publication number
DE60013526D1
DE60013526D1 DE60013526T DE60013526T DE60013526D1 DE 60013526 D1 DE60013526 D1 DE 60013526D1 DE 60013526 T DE60013526 T DE 60013526T DE 60013526 T DE60013526 T DE 60013526T DE 60013526 D1 DE60013526 D1 DE 60013526D1
Authority
DE
Germany
Prior art keywords
crataegus
overweight
obesity
treatment
adrenergic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60013526T
Other languages
English (en)
Other versions
DE60013526T2 (de
Inventor
Bojidar M Stankov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambros Pharma SRL
Original Assignee
Ambros Pharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambros Pharma SRL filed Critical Ambros Pharma SRL
Application granted granted Critical
Publication of DE60013526D1 publication Critical patent/DE60013526D1/de
Publication of DE60013526T2 publication Critical patent/DE60013526T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60013526T 1999-10-20 2000-10-17 Zusammensetzung enthaltend Verbindungen mit adrenergischer Aktivität und pflanzliche Extrakten von Crataegus und Gingko zur Behandlung von Übergewicht und Fettleibigkeit Expired - Lifetime DE60013526T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI992201 1999-10-20
IT1999MI002201A IT1314199B1 (it) 1999-10-20 1999-10-20 Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'

Publications (2)

Publication Number Publication Date
DE60013526D1 true DE60013526D1 (de) 2004-10-14
DE60013526T2 DE60013526T2 (de) 2005-11-17

Family

ID=11383822

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013526T Expired - Lifetime DE60013526T2 (de) 1999-10-20 2000-10-17 Zusammensetzung enthaltend Verbindungen mit adrenergischer Aktivität und pflanzliche Extrakten von Crataegus und Gingko zur Behandlung von Übergewicht und Fettleibigkeit

Country Status (5)

Country Link
US (1) US6447818B1 (de)
EP (1) EP1093817B1 (de)
AT (1) ATE275409T1 (de)
DE (1) DE60013526T2 (de)
IT (1) IT1314199B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340482B1 (en) * 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
FR2842425B1 (fr) * 2002-07-16 2005-04-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
US6565847B1 (en) * 2002-07-03 2003-05-20 Vitacost.Com, Inc. Thermogenic weight management composition
US7115285B2 (en) * 2003-03-14 2006-10-03 Eurark, Llc Composition and method for appetite and craving suppression and mood enhancement
US6861073B2 (en) * 2003-04-11 2005-03-01 Paul Ling Tai Dysfunctional satiety center syndrome and method of treatment therefor
FR2865652B1 (fr) * 2004-02-02 2009-10-02 Greenpharma Sas Utilisation d'extraits de plantes et de molecules purifiees pour des compositions cosmetique, nutraceutique ou pharmaceutique a action amincissante lipolytique.
WO2005089783A1 (ja) * 2004-03-22 2005-09-29 Shiseido Co., Ltd. リポプロテインリパーゼ活性抑制剤
JP2009544861A (ja) * 2006-07-28 2009-12-17 ヴォルカン，アルベルト 果実処理、特にリンゴの産業廃棄物から生じる植物性の製品に基づく組成物、該組成物の使用、処理手順およびそのように得られた製品
TWI519307B (zh) * 2007-10-24 2016-02-01 Suntory Holdings Ltd The ligand of peroxisome proliferator activated receptor (PPAR)
WO2017161379A1 (en) * 2016-03-18 2017-09-21 4Life Patents, Llc Methods and compositions for weight control
CN110772577A (zh) * 2019-12-20 2020-02-11 北京康比特体育科技股份有限公司 一种减肥组合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE901791C (de) * 1950-07-29 1954-01-14 Capehart Farnsworth Corp Fernsehkameraroehre
CN1122655A (zh) * 1994-11-05 1996-05-22 邓忠元 银杏叶系列袋泡茶
ATE453385T1 (de) * 1996-09-30 2010-01-15 Dennis Jones Regulation von körpergewicht durch materialien basierend auf zitrusvariationen
US6224873B1 (en) * 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
PT1030659E (pt) * 1997-11-14 2003-09-30 Warner Lambert Co Composicao farmaceutica compreendendo efedrina-(+) antagonista do receptor h1.
JPH11228434A (ja) * 1998-02-09 1999-08-24 Pola Chem Ind Inc エネルギー利用促進剤
US6277396B1 (en) * 2000-05-11 2001-08-21 Maximum Human Performance, Inc. Dietary supplement containing a thermogenic substance and an adrenal support substance

Also Published As

Publication number Publication date
ITMI992201A1 (it) 2001-04-20
IT1314199B1 (it) 2002-12-06
EP1093817B1 (de) 2004-09-08
DE60013526T2 (de) 2005-11-17
EP1093817A1 (de) 2001-04-25
ATE275409T1 (de) 2004-09-15
ITMI992201A0 (it) 1999-10-20
US6447818B1 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
TW366286B (en) Flavour-masked pharmaceutical compositions
MXPA04007980A (es) Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
US20060269567A1 (en) Universal detoxifying composition
KR910007539A (ko) 인체 지방축적물 치료용 조성물
DE60013526D1 (de) Zusammensetzung enthaltend Verbindungen mit adrenergischer Aktivität und pflanzliche Extrakten von Crataegus und Gingko zur Behandlung von Übergewicht und Fettleibigkeit
SI1341524T1 (sl) Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
KR970061244A (ko) 치매 치료용 약학 조성물
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
HK1069327A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
HUP0203449A2 (hu) L-karnitin-számazékokat és ginkgo biloba kivonatot tartalmazó készítmény keringési rendellenességek megelőzésére és/vagy kezelésére
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
KR19980072723A (ko) 한약 조성물 및 이의 제약학적 제제
RU2000114174A (ru) Применение фосфолипидных комплексов экстрактов из vitis vinifera в качестве противоатеросклеротических агентов
DE69419854T2 (de) Arzneimittelzusammensetzung zur Prophylaxe und Behandlung vorzeitigen Samenergusses
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
EP1393738A4 (de) Arzneimittel gegen diabetes
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
AU2003273444B2 (en) Use of Ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
Bödigheimer et al. Effectiveness of hawthorn extract at a dosage of 3 x 100 mg per day. Multicentre double-blind trial with 85 NYHA stage II heart failure patients.
RU95119282A (ru) Композиция ингредиентов для лекарственного средства
ATE332693T1 (de) Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose
RU2259205C1 (ru) Лечебно-профилактическое средство при заболеванях мочеполовой системы у мужчин

Legal Events

Date Code Title Description
8364 No opposition during term of opposition